NAFLD (Non-Alcoholic Fatty Liver Disease) Activity Score

ورودی‌های بالینی بیمار

پنل نتیجه و تصمیم بالینی
در انتظار ورودی‌ها
nafld activity score
—points
آماده برای ارزیابی

پارامترهای بالینی بیمار را در فرم روبرو وارد کنید و روی «محاسبه» کلیک نمایید تا نمره، طبقه خطر و اقدامات فوری نمایش داده شوند.

طبقات خطر و بازه‌های امتیاز:
  • No activity0–0
  • Mild activity1–2
  • Moderate activity3–5
  • Marked activity6–8
Direct Clinical Answer

The NAFLD (Non-Alcoholic Fatty Liver Disease) Activity Score calculates assessing gastrointestinal disease severity, endoscopic intervention urgency, and rebleeding risk. Key inputs include steatosis. Scores guide timing emergent endoscopy, initiating high-dose proton pump inhibitor infusions, or obtaining surgical consultation. This standardized assessment improves clinical decision safety and bedside patient management.

Clinical Guidelines & Evidence

Diagnoses steatohepatitis based on histological findings in NAFLD patients. The NAS evaluates disease activity by scoring three histological features: steatosis, lobular inflammation, and hepatocellular ballooning.

Clinical Indication

The NAFLD (Non-Alcoholic Fatty Liver Disease) Activity Score is indicated for bedside clinical practice to support Diagnoses steatohepatitis based on histological findings in NAFLD patients. The NAS evaluates disease activity by scoring three histological features: steatosis, lobular inflammation, and hepatocellular ballooning.. It assists healthcare providers in standardizing clinical assessment and therapeutic decision-making.

Target Population

Target population comprises Patients presenting with upper or lower gastrointestinal hemorrhage, acute pancreatitis, acute liver failure, or inflammatory bowel disease. Clinical application is indicated across Endoscopy suites, emergency GI triage, acute medical floors, and hepatology services.

Limitations & Contraindications

Initial hemoglobin values in hyperacute hemorrhage may falsely appear normal prior to complete extravascular-to-intravascular fluid equilibration.

Clinical Pearls & Action Plan

Aggressive intravascular volume resuscitation and blood product support must precede diagnostic or therapeutic endoscopy. Guideline pearl: NAS ≥4 is recommended for admission into interventional trials for NASH.

Formula & Variables:

NAS = Steatosis score (0-3) + Lobular inflammation score (0-3) + Hepatocellular ballooning score (0-2)

Input Parameters

NameTypeRequiredDescription
steatosisstringYesPercentage of hepatocytes containing fat droplets on liver biopsy
lobular_inflammationstringYesNumber of inflammatory foci per 200× microscopic field
ballooningstringYesHepatocellular ballooning (enlarged hepatocytes with rarefied cytoplasm)

Score Interpretation & Guidance

RangeStageDescription
0–0No activityNo NAFLD activity
1–2Mild activityMild NAFLD activity
3–5Moderate activityModerate NAFLD activity
6–8Marked activityMarked NAFLD activity

Evidence-Based References (EBM)

  • Kleiner DE, Brunt EM, Van Natta M, Behling C, Contos MJ, Cummings OW, et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology. 2005 Jun;41(6):1313-21. doi: 10.1002/hep.20701.DOI: 10.1002/hep.20701
  • Brunt EM, Kleiner DE, Wilson LA, Belt P, Neuschwander-Tetri BA; NASH Clinical Research Network (CRN). Nonalcoholic fatty liver disease (NAFLD) activity score and the histopathologic diagnosis in NAFLD: distinct clinicopathologic meanings. Hepatology. 2011 Mar;53(3):810-20. doi: 10.1002/hep.24127.DOI: 10.1002/hep.24127

Related calculators